The probability of drug interactions increases when genetic polymorphisms are considered, indicating that pharmacogenetic assessment may be useful in predicting the presence and severity of ...
Background: Failure to detect significant drug interactions may result in adverse outcomes. While proper screening and management of drug interactions can prevent the majority of adverse events, ...
MiraLAX (polyethylene glycol 3350) is an over-the-counter drug used to treat constipation in adults and certain children. MiraLAX can interact with some supplements and other medications, including ...
The assessment of causation for a potential drug interaction requires thoughtful consideration of the properties of both the object and precipitant drugs, patient-specific factors, and the possible ...
Ingrezza (valbenazine) has potential interactions with other medications and some supplements. For example, Ingrezza can interact with the drugs paroxetine and ketoconazole. Ingrezza and Ingrezza ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback